Mannucci P M, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson S U, Purcell R H
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital, Milan, Italy.
Ann Intern Med. 1994 Jan 1;120(1):1-7. doi: 10.7326/0003-4819-120-1-199401010-00001.
To determine whether an outbreak of hepatitis A virus (HAV) infection that occurred in 52 patients with hemophilia in Italy was acquired through infusion of contaminated factor VIII or through environmental enteric transmission.
A case-control study and a molecular analysis of HAV sequences from implicated lots of factor VIII and from infected patients.
The first 29 patients with hemophilia and jaundice in whom hepatitis A developed were compared with one to three matched controls with hemophilia but no jaundice.
Type of concentrate and batches infused, number of doses, contacts with persons who had jaundice or hepatitis A, travel abroad to countries reported to have a high attack rate for hepatitis A, and consumption of raw shellfish. Hepatitis A viral sequences sought by polymerase chain reaction in lots of factor VIII and in serial serum samples from two patients with hemophilia in whom hepatitis A developed. Amplification by polymerase chain reaction of cDNA transcribed with reverse transcriptase from matched sets of factor VIII and recipient serum samples. Determination of nucleotide sequence of amplified hepatitis A virus genome.
Case patients were neither more nor less likely than controls to have traveled to high-risk countries, consumed raw shellfish, or had contact with persons with jaundice. Case patients were more likely than controls to have received a factor VIII concentrate treated with a solvent-detergent mixture to inactivate viruses (odds ratio, infinity; 95% CI, 4.5 to infinity) and to have had larger infusions of the concentrate during the presumed HAV incubation period (odds ratio, 8.54; CI, 2.78 to 27.5). Hepatitis A viral sequences were found in 5 of 12 tested lots of factor VIII. Genomic sequences of HAV obtained for two matched sets of factor VIII and recipient serum samples were identical within each set but different for the two sets.
Hepatitis A was transmitted by a factor VIII concentrate treated by a virucidal method (solvent-detergent) that ineffectively inactivates nonenveloped viruses.
确定意大利52例血友病患者中发生的甲型肝炎病毒(HAV)感染暴发是通过输注受污染的凝血因子VIII还是通过环境肠道传播获得的。
一项病例对照研究以及对来自受牵连的凝血因子VIII批次和感染患者的HAV序列进行分子分析。
将首批29例患甲型肝炎的血友病和黄疸患者与一至三名匹配的无黄疸血友病对照进行比较。
浓缩物类型和输注批次、剂量数量、与黄疸或甲型肝炎患者的接触情况、前往据报道甲型肝炎发病率高的国家的出国旅行情况以及生贝类消费情况。通过聚合酶链反应在凝血因子VIII批次以及两名患甲型肝炎的血友病患者的系列血清样本中寻找甲型肝炎病毒序列。用逆转录酶从匹配的凝血因子VIII和受血者血清样本中转录的cDNA进行聚合酶链反应扩增。测定扩增的甲型肝炎病毒基因组的核苷酸序列。
病例患者前往高危国家旅行、食用生贝类或与黄疸患者接触的可能性与对照患者无异。病例患者比对照患者更有可能接受过用溶剂-去污剂混合物处理以灭活病毒的凝血因子VIII浓缩物(比值比,无穷大;95%可信区间,4.5至无穷大),并且在假定的HAV潜伏期内输注的浓缩物量更大(比值比,8.54;可信区间,2.78至27.5)。在12个检测的凝血因子VIII批次中有5个批次发现了甲型肝炎病毒序列。从两组匹配的凝血因子VIII和受血者血清样本获得的HAV基因组序列在每组内相同,但两组之间不同。
甲型肝炎是通过一种用杀病毒方法(溶剂-去污剂)处理的凝血因子VIII浓缩物传播的,这种方法不能有效灭活无包膜病毒。